The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results from the first in human study of activin-A inhibitor, STM434, in patients with granulosa cell ovarian cancer and other advanced solid tumors.
 
David Michael Hyman
Consulting or Advisory Role - Atara Biotherapeutics
Research Funding - AstraZeneca; Atara Biotherapeutics; Puma Biotechnology
Travel, Accommodations, Expenses - AstraZeneca; Genentech; Puma Biotechnology
 
Drew W. Rasco
Research Funding - Atara Biotherapeutics
 
Jeffrey R. Infante
Consulting or Advisory Role - Atara Biotherapeutics
Research Funding - Atara Biotherapeutics
 
Joyce F. Liu
Research Funding - Atara Biotherapeutics
 
Esther Welkowsky
Employment - Atara Biotherapeutics
Stock and Other Ownership Interests - Atara Biotherapeutics
Travel, Accommodations, Expenses - Atara Biotherapeutics
 
Dung Luong Thai
Employment - Atara Biotherapeutics
Stock and Other Ownership Interests - Atara Biotherapeutics
Travel, Accommodations, Expenses - Atara Biotherapeutics
 
Christopher M. Haqq
Employment - Atara Biotherapeutics
Leadership - Atara Biotherapeutics
Stock and Other Ownership Interests - Atara Biotherapeutics